Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid, SuperArray Bioscience

Premium

Cepheid this week launched its CE-marked Smart CMV in vitro diagnostic test in Europe for the SmartCycler real-time PCR platform. The test is intended for rapid detection and quantitation of CMV viral load for hospitals, university research labs, and government agencies, the company said. With automation, the SmartCycler system can deliver "highly accurate and consistent test results from prepared biological samples in approximately 30-40 minutes," Cepheid added.


SuperArray Bioscience last week launched its ArrayGrade FFPE RNA Isolation Kit for isolating RNA from formalin-fixed paraffin-embedded samples for microarray-based gene expression analysis.

The company claims the kit can help increase percent positive calls on high-density microarrays by reversing more of the cross-links introduced by the archiving process and recommended its use in cancer and pathology research.

Filed under

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.